HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 342 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,937,120 | -3.3% | 155,422 | -8.7% | 0.07% | +4.3% |
| Q2 2023 | $6,139,042 | -14.6% | 170,198 | -9.6% | 0.07% | -17.6% |
| Q1 2023 | $7,186,747 | -34.9% | 188,184 | -3.1% | 0.08% | -38.4% |
| Q4 2022 | $11,045,997 | +45.1% | 194,130 | +0.8% | 0.14% | +34.0% |
| Q3 2022 | $7,615,000 | -15.5% | 192,599 | -5.9% | 0.10% | -10.4% |
| Q2 2022 | $9,009,000 | +76.0% | 204,745 | +59.5% | 0.12% | +113.0% |
| Q1 2022 | $5,120,000 | +1.1% | 128,384 | +1.9% | 0.05% | +5.9% |
| Q4 2021 | $5,064,000 | -0.6% | 125,933 | +0.5% | 0.05% | 0.0% |
| Q3 2021 | $5,097,000 | -5.5% | 125,300 | +5.5% | 0.05% | -3.8% |
| Q2 2021 | $5,393,000 | +12.8% | 118,762 | +3.5% | 0.05% | +6.0% |
| Q1 2021 | $4,783,000 | -5.8% | 114,721 | -3.5% | 0.05% | -13.8% |
| Q4 2020 | $5,079,000 | – | 118,927 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
| BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
| SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
| Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
| Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
| PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
| Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
| Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
| Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |